Form 8-K - Current report:
SEC Accession No. 0001558370-23-019017
Filing Date
2023-11-14
Accepted
2023-11-14 16:05:54
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K miro-20231114x8k.htm   iXBRL 8-K 33678
2 EX-99.1 miro-20231114xex99d1.htm EX-99.1 206315
3 GRAPHIC miro-20231114xex99d1001.jpg GRAPHIC 11279
  Complete submission text file 0001558370-23-019017.txt   389494

Data Files

Seq Description Document Type Size
4 EX-101.SCH miro-20231114.xsd EX-101.SCH 3129
5 EX-101.LAB miro-20231114_lab.xml EX-101.LAB 15920
6 EX-101.PRE miro-20231114_pre.xml EX-101.PRE 10320
8 EXTRACTED XBRL INSTANCE DOCUMENT miro-20231114x8k_htm.xml XML 4922
Mailing Address 6455 FLYING CLOUD DRIVE SUITE 107 EDEN PRAIRIE MN 55344
Business Address 6455 FLYING CLOUD DRIVE SUITE 107 EDEN PRAIRIE MN 55344 (612)202-7026
Miromatrix Medical Inc. (Filer) CIK: 0001527096 (see all company filings)

EIN.: 271285782 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40518 | Film No.: 231405929
SIC: 2836 Biological Products, (No Diagnostic Substances)